Dr. Zadeh is Professor of Medicine at the Johns Hopkins University School of Medicine and Director of Cardiac Computed Tomography in the Division of Cardiology at the Johns Hopkins Hospital in Baltimore, MD. After attending medical school in Germany and completing internships in medicine and surgery in Germany and Britain, he spent several years in cardiovascular research at the University of California at San Diego to study coronary artery disease using intravascular ultrasound. He then completed his postgraduate training in Philadelphia and Dallas to join the cardiology faculty at Johns Hopkins Hospital after a CT imaging fellowship in 2005. Dr. Zadeh directs the CT coronary angiography core laboratory for the CorE-320 multicenter trial and is member of its steering committee. He is also co-director of the SCCT Board Review Course and editor of the SCCT Board Review Preparation Book. Dr. Zadeh's particular clinical and investigational focus is the pursuit of strategies to better identify patients at risk for future cardiac events using cardiac imaging. He reviews manuscripts for numerous scientific journals, including JACC, JACCimaging, JCCT, AJR, Heart, AJC, and is an author of articles in Circulation, New England Journal of Medicine, JACC, AHJ, and others. Dr. Arbab is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Heart Attack, Apoplexy, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Dr. Brian Gustav Kral is Assistant Professor in the Division of Cardiology and General Internal Medicine as well as Assistant Professor of Radiology and Radiological Sciences at the Johns Hopkins School of Medicine. He is currently engaged in research on genetic and biological mechanisms of coronary atherosclerosis with an emphasis on plaque morphology and composition as well as coronary blood flow at different stages of disease progression. Dr. Kral received his undergraduate degree in economics and pre-medicine from The Johns Hopkins University. He received a master’s in public health from The Johns Hopkins School of Public Health. He also earned a medical degree from The Johns Hopkins School of Medicine. Dr. Kral completed his residency at the Mayo Graduate School of Medicine. He rejoined the Johns Hopkins community as a fellow in 2005 where he remained on Faculty after completion of his training. Besides his teaching and clinical engagements, Dr. Kral is currently the Program Director of Nuclear Cardiology at the Johns Hopkins School of Medicine. Dr. Kral is also Director of Clinical Studies for The Johns Hopkins GeneSTAR Research Program. The program aims to identify genetic and biological determinants of subclinical and clinical atherosclerotic disease and thrombosis in individuals with a strong family history of early-onset coronary artery disease. He has been recognized with the Stanley L. Blumenthal Cardiology Research Award for outstanding clinical research in cardiovascular disease from The Johns Hopkins Medical Institutions. Dr. Kral is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Apoplexy, Coronary Heart Disease, Heart Attack, Pacemaker Implantation, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Mark Applefeld is a Cardiologist in Baltimore,, Maryland. Dr. Applefeld is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Angina, Cardiomyopathy, and High Cholesterol.

Lewis Becker is a Cardiologist in Baltimore, Maryland. Dr. Becker is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Heart Attack, and Acute Coronary Syndrome.

Roy Ziegelstein is a Cardiologist in Baltimore,, Maryland. Dr. Ziegelstein is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Cardiomyopathy, and Angina.

Jeffrey Cole is a Cardiologist in Baltimore, Maryland. Dr. Cole is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Angina, Partial Atrioventricular Canal, and Endocardial Cushion Defect.

Frederick Kuhn is a Cardiologist in Baltimore,, Maryland. Dr. Kuhn is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Arrhythmias, Catecholaminergic Polymorphic Ventricular Tachycardia, and Ventricular Tachycardia.

Stephen Plantholt is a Cardiologist in Baltimore, Maryland. Dr. Plantholt is rated as a Distinguished provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Coronary Heart Disease, Aortic Valve Stenosis, Bicuspid Aortic Valve, Heart Attack, and Pacemaker Implantation.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Thorsten Leucker is a Cardiologist in Baltimore, Maryland. Dr. Leucker is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Apoplexy, Heart Attack, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Dr. Allison Hays is a general cardiologist and Medical Director of Echocardiography Programs at the Johns Hopkins Hospital. She is also an assistant professor at the Johns Hopkins University School of Medicine. Dr. Hays graduated from Stanford University with degrees in biology and English. She received her medical training at the Columbia University College of Physicians and Surgeons and did her residency at the New York Presbyterian Hospital at Columbia. Dr. Hays pursued cardiology fellowships at New York University Medical Center and at the Johns Hopkins University School of Medicine. Dr. Hays studies ways to use noninvasive imaging to detect cardiovascular disease. She has advanced multimodality imaging training from Johns Hopkins and attends in the Adult Echocardiography Lab at Johns Hopkins Hospital. In terms of research, she uses Cardiac MRI as a tool to study coronary and systemic endothelial function. Dr. Hays is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. Her top areas of expertise are Familial Ventricular Tachycardia, Cardiomyopathy, COVID-19, Heart Attack, and Tissue Biopsy.

Dr. Michael Kelemen is a general cardiologist for the Johns Hopkins Heart and Vascular Institute in the Department of Medicine. His research in cardiac rehabilitation demonstrated the power of exercise as a treatment for hypertension, high cholesterol, and recovery from cardiac events. Dr. Kelemen is an associate professor of medicine in the Johns Hopkins School of Medicine. Dr. Kelemen received his medical degree from the University of Pennsylvania Health System School of Medicine. He completed his residency in medicine at University Hospitals of Cleveland, and pursued cardiology fellowships at the University of California, San Francisco School of Medicine and at the Wyman Park Health System in Baltimore. Dr. Kelemen is active in community health issues, having served on the boards of the Health Alliance and The Horizon Foundation, which provide medical and mental health services to underserved populations. As the founding medical director of the Prescribed Active Cardiac Exercises (PACE) program at Catonsville Community College in 1976, he performed the research that demonstrated the benefits of exercise for cardiac patients. Dr. Kelemen is rated as an Advanced provider by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Heart Attack, Apoplexy, Postural Orthostatic Tachycardia Syndrome (POTS), and Brugada Syndrome.